General description
Chlordiazepoxide is a benzodiazepine sold under trade names such as Librax® or Klopoxid for short-term treatment of anxiety or management of acute alcohol withdrawal syndrome. This stable-labeled internal standard is suitable for chlordiazepoxide testing or isotope dilution methods by GC/MS or LC/MS for applications in clinical toxicology, urine drug testing, pain prescription monitoring, or forensic analysis.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Librax is a registered trademark of Valeant Pharmaceuticals North America LLC
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Molecular Weight: 304.79. Empirical Formula: C16D5H9ClN3O. grade: certified reference material. Quality Level: 300. form: liquid. feature: Snap-N-Spike®. /Snap-N-Shoot®. . packaging: ampule of 1 . mL. manufacturer/tradename: Cerilliant®. . drug control: Narcotic Licence Schedule B (Switzerland). concentration: 100 . μ. g/mL in methanol. technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): clinical testing. format: single component solution. storage temp.: −. 20°C. SMILES string: [2H]C1: C([2H])C([2H]): C([2H])C([2H]): C1C2: [N+]([O-])CC(NC): NC3: C2C: C(Cl)C: C3. InChI: 1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9H,10H2,1H3,(H,18,19)/i2D,3D,4D,5D,6D. InChI key: ANTSCNMPPGJYLG-VIQYUKPQSA-N. Pictograms: GHS02,GHS06,GHS08. Signal Word: Danger. Hazard Statements: H225 - H301 + H311 + H331 - H370. Precautionary Statements: P210 - P260 - P280 - P301 + P310 - P311. Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1. Storage Class Code: 3 - Flammable liquids. WGK: WGK 1. Flash Point(F): 49.5 °F - closed cup. Flash Point(C): 9.7 °C - closed cup.- UPC:
- 51101607
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- C-912-1ML
- CAS:
- 65891-81-8
- DEA:
- Yes
akash.verma@cenmed.com
(732) 447-1115





